Jingquan Jia

Positions:

Assistant Professor of Medicine

Medicine, Medical Oncology
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Education:

M.D. 1999

Beijing Medical University (China)

Ph.D. 2008

Duke University

Postdoctoral Fellow, Department Of Medicine

Duke University

Internal Medicine Intern, Vidant Medical Center

East Carolina University

Internal Medicine Residency, Vidant Medical Center

East Carolina University

Hematology Oncology Fellowship, Duke University Medical Center

Duke University

Grants:

A Phase II, Multicenter, Single-Arm Study of Pemigatinib in Patients with Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations

Administered By
Duke Cancer Institute
Awarded By
Academic and Community Cancer Research United
Role
Principal Investigator
Start Date
End Date

A Pilot Study of a Micro-Organosphere Drug Screen Platform to Lead Care in Advanced Cancers

Administered By
Duke Cancer Institute
Awarded By
Xilis, Inc.
Role
Principal Investigator
Start Date
End Date

GO42661 A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Role
Principal Investigator
Start Date
End Date

A Phase II Randomized Study of Atezolizumab plus Multi-Kinase Inhibitor versus Multi-Kinase Inhibitor Alone in Subjects with Unresectable, Advanced Hepatocellular Carcinoma Who Previously Received Atezolizumab Plus Bevacizumab (ACCRU-2008)

Administered By
Duke Cancer Institute
Awarded By
Genentech, Inc.
Role
Principal Investigator
Start Date
End Date

STOOL COLLECTION STUDY IN CANCER PATIENTS TREATED WITH IRINOTECAN-BASED REGIMENS

Administered By
Duke Cancer Institute
Awarded By
Symberix
Role
Principal Investigator
Start Date
End Date